dc.contributor.author |
Petri, A |
en |
dc.contributor.author |
Alexandratou, E |
en |
dc.contributor.author |
Kyriazi, M |
en |
dc.contributor.author |
Rallis, M |
en |
dc.contributor.author |
Roussis, V |
en |
dc.contributor.author |
Yova, D |
en |
dc.date.accessioned |
2014-03-01T02:08:23Z |
|
dc.date.available |
2014-03-01T02:08:23Z |
|
dc.date.issued |
2012 |
en |
dc.identifier.issn |
15721000 |
en |
dc.identifier.uri |
https://dspace.lib.ntua.gr/xmlui/handle/123456789/29652 |
|
dc.subject |
Antioxidants |
en |
dc.subject |
Fospeg |
en |
dc.subject |
IPDT |
en |
dc.subject |
Photosensitivity |
en |
dc.subject |
Pinus halepensis |
en |
dc.subject.other |
antioxidant |
en |
dc.subject.other |
fospeg |
en |
dc.subject.other |
liposome |
en |
dc.subject.other |
photosensitizing agent |
en |
dc.subject.other |
Pinus halepensis extract |
en |
dc.subject.other |
plant extract |
en |
dc.subject.other |
unclassified drug |
en |
dc.subject.other |
animal model |
en |
dc.subject.other |
animal tissue |
en |
dc.subject.other |
article |
en |
dc.subject.other |
bark |
en |
dc.subject.other |
cancer therapy |
en |
dc.subject.other |
clinical effectiveness |
en |
dc.subject.other |
controlled study |
en |
dc.subject.other |
digital imaging |
en |
dc.subject.other |
erythema |
en |
dc.subject.other |
evaluation |
en |
dc.subject.other |
Fospeg interstitial photodynamic therapy |
en |
dc.subject.other |
male |
en |
dc.subject.other |
mouse |
en |
dc.subject.other |
nonhuman |
en |
dc.subject.other |
outcome assessment |
en |
dc.subject.other |
photodynamic therapy |
en |
dc.subject.other |
photosensitivity |
en |
dc.subject.other |
pine |
en |
dc.subject.other |
priority journal |
en |
dc.subject.other |
process optimization |
en |
dc.subject.other |
prostate cancer |
en |
dc.subject.other |
tail |
en |
dc.subject.other |
treatment duration |
en |
dc.subject.other |
tumor regression |
en |
dc.subject.other |
tumor volume |
en |
dc.subject.other |
Animalia |
en |
dc.subject.other |
Murinae |
en |
dc.subject.other |
Mus |
en |
dc.subject.other |
Pinus halepensis |
en |
dc.title |
Combination of Fospeg-IPDT and a natural antioxidant compound prevents photosensitivity in a murine prostate cancer tumour model |
en |
heal.type |
journalArticle |
en |
heal.identifier.primary |
10.1016/j.pdpdt.2011.11.002 |
en |
heal.identifier.secondary |
http://dx.doi.org/10.1016/j.pdpdt.2011.11.002 |
en |
heal.publicationDate |
2012 |
en |
heal.abstract |
Background: The aim of the present research was to investigate the potential use of a natural compound rich in antioxidant agents, derived from . Pinus halepensis (. P. halepensis), to prevent PDT induced photosensitivity. The present research progressed in two levels. The first one evolved the optimization of Fospeg-interstitial photodynamic therapy (IPDT) in a prostate cancer animal model. In the second one, . P. halepensis bark extract, was evaluated for its potential use to prevent photosensitivity. Methods: Two sets of experiments were performed, IPDT only and IPDT in the presence of antioxidant. For both of them, Fospeg was administrated intravenously to SCID mice bearing prostate cancer, followed by IPDT after 6. h. For the IPDT. +. antioxidant experiments, . P. halepensis was injected intratumourously 1. h prior the tumour illumination. Treatment outcome was monitored twice a week by an imaging system and by measuring tumour dimensions using a caliper. Photosensitivity was assessed by monitoring erythema of the tail using the imaging system. Results: IPDT with Fospeg and 15. J total light energy is a therapeutic scheme that can eliminate tumours in the murine model of prostate cancer. Two months after complete tumour remission no tumour recurrence was observed. Also, the cosmetic outcome of the research was excellent. The major drawback of this treatment scheme was that 90% of the animals developed photosensitivity. The addition of . P. halepensis bark extract resulted in prevention of the photosensitivity, leaving PDT outcome unaffected. Conclusions: The combined use of PDT and the used antioxidant agent could broaden the implementation of photodynamic therapy, by eliminating photosensitivity. © 2011 Elsevier B.V.. |
en |
heal.journalName |
Photodiagnosis and Photodynamic Therapy |
en |
dc.identifier.doi |
10.1016/j.pdpdt.2011.11.002 |
en |
dc.identifier.volume |
9 |
en |
dc.identifier.issue |
2 |
en |
dc.identifier.spage |
100 |
en |
dc.identifier.epage |
108 |
en |